These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 12421226)

  • 21. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso.
    Zeba MT; Sanou M; Bisseye C; Kiba A; Nagalo BM; Djigma FW; Compaoré TR; Nebié YK; Kienou K; Sagna T; Pietra V; Moret R; Simporé J
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s54-7. PubMed ID: 24599906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study.
    Garson JA; Clewley JP; Simmonds P; Zhang LQ; Mori J; Ring C; Follett EA; Dow BC; Martin S; Gunson H
    Vox Sang; 1992; 62(4):218-23. PubMed ID: 1322612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serological and molecular genetic markers of hepatitis C virus in infected donors].
    Zubkova NV; Filatova EV; Zubov SV
    Vopr Virusol; 2010; 55(5):34-6. PubMed ID: 21260994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):208-19. PubMed ID: 7496119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
    Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
    Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
    Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
    Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.
    François M; Dubois F; Brand D; Bacq Y; Guerois C; Mouchet C; Tichet J; Goudeau A; Barin F
    J Clin Microbiol; 1993 May; 31(5):1189-93. PubMed ID: 7684749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations.
    Grabarczyk P; Kubicka-Russel D; Kopacz A; Liszewski G; Sulkowska E; Zwolińska P; Madaliński K; Marek M; Szabelewska M; Świątek E; Laskus T; Radkowski M
    J Med Virol; 2020 Mar; 92(3):339-347. PubMed ID: 31670401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
    Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
    Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
    [No Abstract]   [Full Text] [Related]  

  • 39. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
    Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
    Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
    Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
    Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.